Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in BRAFV600E Colorectal Cancer.
Saved in:
| Title: | Convergent Therapeutic Strategies to Overcome the Heterogeneity of Acquired Resistance in BRAFV600E Colorectal Cancer. |
|---|---|
| Authors: | Hazar-Rethinam M; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Kleyman M; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Han GC; Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts., Liu D; Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts., Ahronian LG; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Shahzade HA; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Chen L; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Parikh AR; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Allen JN; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Clark JW; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Kwak EL; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Faris JE; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Murphy JE; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Hong TS; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts., Van Seventer EE; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Nadres B; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Hong CB; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Gurski JM Jr; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Medicine, Harvard Medical School, Boston, Massachusetts., Jessop NA; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Dias-Santagata D; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Iafrate AJ; Massachusetts General Hospital Cancer Center, Boston, Massachusetts.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts., Van Allen EM; Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts., Corcoran RB; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. rbcorcoran@partners.org.; Department of Medicine, Harvard Medical School, Boston, Massachusetts. |
| Source: | Cancer discovery [Cancer Discov] 2018 Apr; Vol. 8 (4), pp. 417-427. Date of Electronic Publication: 2018 Feb 05. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
